24 Ulcerative Colitis Clinical Trials in Atlanta, GA (2026)

Q: Are there ulcerative colitis clinical trials in Atlanta?

Yes, there are 24 ulcerative colitis clinical trials currently recruiting in Atlanta, GA.

Q: How do I join a clinical trial in Atlanta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you.

Q: Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Ulcerative Colitis Studies in Atlanta

NCT06787937Recruiting

Communicating About Nicotine Reduction in Cigarettes

The goal of this clinical trial is to learn how a messaging campaign about reduced nicotine cigarettes and policy, combined with the use of very low nicotine cigarettes (VLNCs), affects smoking behavi...

Atlanta, GANA1,230 participantsGeorgia State University

View Study Details

NCT05219110Recruiting

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E...

Atlanta, GANA1,040 participantsUniversity of Calgary

View Study Details

NCT04633655Recruiting

International CIPN Assessment and Validation Study

This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an in...

Atlanta, GA1,000 participantsUniversity of Milano Bicocca

View Study Details

NCT06586515Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

The main purpose of this study is to assess safety \& tolerability and antitumor activity of LY3962673 as monotherapy and in combination with other chemotherapy agents in participants with KRAS G12D-m...

Atlanta, GAPHASE1630 participantsEli Lilly and Company

View Study Details

NCT07226765Recruiting

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in adults with obstructive sleep apnea (OSA) who are no...

Atlanta, GAPHASE3250 participantsAmgen

View Study Details

NCT05442567Recruiting

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this...

Atlanta, GAPHASE3240 participantsTakeda

View Study Details

NCT03373968Recruiting

Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been previously treated in one of the GIVINOSTAT st...

Atlanta, GAPHASE2206 participantsItalfarmaco

View Study Details

NCT05350332Recruiting

Effects of Lung Volume on Upper Airway Patency During Drug Induced Sleep Endoscopy

Obstructive sleep apnea (OSA) is a disorder where a person has recurrent choking episodes during sleep. Surgery can treat OSA and drug induced sleep endoscopy (DISE) is a procedure that surgeons use t...

Atlanta, GANA151 participantsEmory University

View Study Details

NCT04844606Recruiting

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks ...

Atlanta, GAPHASE3150 participantsEli Lilly and Company

View Study Details

NCT06537258Recruiting

Heart Rate Variability and Inflammatory Bowel Disease

The goals of this study are to test the effectiveness of a virtually delivered, group-based coping skills treatment program incorporating heart rate variability biofeedback to target autonomic dysfunc...

Atlanta, GANA128 participantsEmory University

View Study Details

NCT04390035Recruiting

BFRT in Adolescents After ACL Reconstruction

This is an interventional study that will examine effects of blood flow restriction training (BFRT) in adolescents aged 12-18 after anterior cruciate ligament reconstruction surgery (ACLR). The study ...

Atlanta, GANA120 participantsChildren's Healthcare of Atlanta

View Study Details

NCT07071519Recruiting

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how Risankizumab...

Atlanta, GAPHASE3120 participantsAbbVie

View Study Details

NCT07158242Recruiting

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

This Phase III, randomized, double-blind, multicenter, induction and maintenance study will evaluate the safety and efficacy of Afimkibart (RO7790121) in pediatric participants with moderate to severe...

Atlanta, GAPHASE3100 participantsHoffmann-La Roche

View Study Details

NCT06595160Recruiting

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma....

Atlanta, GA87 participantsEmory University

View Study Details

NCT07483073Recruiting

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Study IIBD is a master protocol that will support a collection of individual sub studies that share key design components. Participants will be assigned to the appropriate study prior to randomization...

Atlanta, GAPHASE260 participantsEli Lilly and Company

View Study Details

NCT04457154Recruiting

Pediatric Post-Approval Registry

This registry is a prospective, multi-center, single-arm study of pediatric subjects (ages 18-21 years) who are undergoing implant of the Inspire Upper Airway Stimulation (UAS) System for the treatmen...

Atlanta, GA60 participantsInspire Medical Systems, Inc.

View Study Details

NCT06138639Recruiting

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

This is a multicenter, open-label, non-randomized study to investigate the safety, tolerability, and efficacy of a single intravenous (IV) infusion of SGT-003 in participants with Duchenne muscular dy...

Atlanta, GAPHASE160 participantsSolid Biosciences Inc.

View Study Details

NCT07223944Recruiting

A Gaucher Disease Gene Therapy Trial With FLT201

This study is a Phase 3, non-randomized, multicenter, efficacy and safety study in adult patients with Gaucher disease Type 1, on stable treatment with enzyme replacement therapy (ERT) or substrate re...

Atlanta, GAPHASE345 participantsSpur Therapeutics

View Study Details

NCT06709534Recruiting

An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors

This clinical trial tests an individualized online home-based exercise program in gynecologic cancer survivors and its impact on gut microbiome (the bacteria and microorganisms that live in the digest...

Atlanta, GANA40 participantsEmory University

View Study Details

NCT06423326Recruiting

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

This phase II trial tests how well gemcitabine, cisplatin and nab-paclitaxel given before surgery (neoadjuvant) works in treating patients with pancreatic cancer that can be removed by surgery (resect...

Atlanta, GAPHASE236 participantsEmory University

View Study Details

NCT06735651Recruiting

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

The goal of this clinical trial is to determine the effectiveness of using a freeze-dried wild blueberry powder on cardiometabolic health, cognitive function, and gut microbiota composition in adult w...

Atlanta, GANA30 participantsGeorgia State University

View Study Details

NCT04906460Recruiting

Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

This is a Phase 1b/2 open-label study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and clinical effects of intravenous (IV) WVE-N531 in patients with Duchenne musc...

Atlanta, GAPHASE126 participantsWave Life Sciences USA, Inc.

View Study Details

NCT05996003Recruiting

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

This is a Phase 2, open-label, multi-center, 2-part study of NS-089/NCNP-02 administered by weekly IV infusion to ambulant boys aged ≥4 to \<15 years with DMD due to mutations amenable to exon 44 skip...

Atlanta, GAPHASE220 participantsNS Pharma, Inc.

View Study Details

NCT06817382Recruiting

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

The primary objective of this study is to evaluate the safety and tolerability of a single dose of INS1201 via IT administration in ambulatory male participants with DMD....

Atlanta, GAPHASE112 participantsInsmed Gene Therapy LLC

View Study Details

About Ulcerative Colitis Clinical Trials in Atlanta

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 24 ulcerative colitis clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 5,841 participants. Research is being sponsored by Georgia State University, University of Calgary, University of Milano Bicocca and 14 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Atlanta — FAQ

Are there ulcerative colitis clinical trials in Atlanta?

Yes, there are 24 ulcerative colitis clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 24 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated September 7, 2026 from ClinicalTrials.gov